Neuro-urology (NLUTD)

The EAU 2026 neuro-urology pathway for neurogenic lower urinary tract dysfunction (NLUTD) — from recognising the neurological cause, through video-urodynamic assessment and lesion-based classification, to an escalating, upper-tract-protective bladder-management ladder (catheterisation settled by shared decision-making, antimuscarinics or beta-3 agonists → botulinum toxin A injected into the detrusor → neuromodulation, augmentation and diversion), plus neurogenic UTI, autonomic dysreflexia, sexual and fertility care, and life-long surveillance. The through-line is “as effective as needed, as non-invasive as possible.” Switch between the visual Pathway map and the phase-by-phase Explorer.